Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

17 Jun 2021 07:00

RNS Number : 1544C
Anpario PLC
17 June 2021
 

17 June 2021

 

Anpario plc("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Peter Lawrence, Chairman, will make the following comments:

 

"The Board would firstly like to thank all our staff and other stakeholders for their continued efforts in ensuring production and delivery of our products to our customers and subsidiaries around the world especially during this challenging period caused by the Covid 19 pandemic.

 

The Company has delivered good sales and improved profit performance with sales at a similar level to last year, which was a very strong comparative period as customers had increased stock levels at the onset of the pandemic. Most regions are performing to plan with China experiencing a very strong performance, benefiting from last year's ban on anti-biotic growth promoters (AGPs) in animal feed. South East Asia's performance is, however, weaker as countries imposed new lockdowns in response to increasing infection rates and, with less tourism which has reduced overall protein consumption.

 

Our Brexit contingency plans are working well, helping to reduce disruption and we now look forward to our efforts coming to fruition now supported by our European stockholding hub.

 

As with most industries, we are experiencing raw material price inflation and some disruption in our supply chains and global shipping operations. However, we are implementing price increases to help mitigate the increase in costs and our export and logistics team is managing to overcome the logistics issues. We expect these challenges to continue until the last quarter of this year.

 

It is worth noting that Anpario's unique formulation technology also benefits customers as we are able to offer solutions which are more cost effective than alternative competitor products.

 

We are encouraged by some recent business development successes including a large Brazilian poultry integrator using Orego-Stim® and growth in Latin America for our aquaculture products, which are currently being launched in specific countries across Asia. Our exciting growth opportunities and strong balance sheet, which is reflected in our strong cash position, gives me confidence that the Company will continue to develop and grow in the years ahead.

 

Finally, this is my last AGM as I retire from the Board today. I would therefore like to take the opportunity to thank all staff and shareholders for their loyalty and support of Anpario in helping to build a successful company which has delivered significant shareholder value. As I hand over the Chair to Kate Allum, I am confident that the board with its newer members, will successfully continue to steer the company through these unusual times to ensure to deliver value to our shareholders.

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 15 September 2021."

 

 

Enquiries:

Anpario plc

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Peel Hunt LLP (NOMAD and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSERTIRLIL
Date   Source Headline
12th Jul 20171:43 pmRNSDirector/PDMR shareholding and Total Voting Rights
30th Jun 20177:00 amRNSDirector/PDMR Shareholding
29th Jun 201712:06 pmRNSResult of AGM
29th Jun 20177:00 amRNSAGM Statement
19th Jun 20172:15 pmRNSHolding(s) in Company
7th Jun 20174:22 pmRNSHolding(s) in Company
5th Jun 201710:20 amRNSDividend date
26th May 20171:53 pmRNSNotice of AGM
23rd May 20173:31 pmRNSHolding(s) in Company
9th May 20175:21 pmRNSDirector/PDMR Shareholding
23rd Mar 20177:00 amRNSDirector Declaration
10th Mar 20177:00 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amBUSFinal Results
1st Mar 20178:39 amRNSHolding(s) in Company
23rd Feb 20177:00 amRNSReplacement Announcement
15th Feb 20174:29 pmRNSHolding(s) in Company
15th Feb 20172:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Feb 20177:00 amRNSAcquisition
2nd Feb 20177:00 amRNSTrading Statement
1st Dec 20167:00 amRNSTotal Voting Rights
22nd Nov 20167:00 amRNSEmployee Share Plan and Directors' Dealing
6th Oct 201611:46 amRNSHolding(s) in Company
16th Sep 20164:36 pmRNSDirector/PDMR Shareholding and Share Plan Limits
14th Sep 20167:30 amBUSHalf-year Report
9th Sep 20163:21 pmRNSTotal Voting Rights
4th Aug 20163:33 pmRNSTotal Voting Rights
4th Aug 20163:32 pmRNSBlock listing Interim Review
6th Jul 20165:00 pmRNSDirector/PDMR Shareholding
6th Jul 20167:00 amRNSHolding(s) in Company
4th Jul 20163:38 pmRNSTotal Voting Rights
29th Jun 20165:17 pmRNSResult of AGM
28th Jun 20167:00 amRNSAGM Statement
13th Jun 20167:00 amRNSTotal Voting Rights
21st Apr 201612:05 pmRNSHolding(s) in Company
8th Mar 20167:00 amBUSFinal Results
29th Feb 20164:59 pmRNSBlocklisting Interim Review
1st Feb 20167:00 amRNSTrading Statement
13th Jan 201611:00 amRNSBoard and Management Changes
3rd Dec 201511:19 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
21st Sep 20155:23 pmRNSDirector/PDMR Shareholding
16th Sep 20154:55 pmRNSDirector/PDMR Shareholding
16th Sep 20157:00 amBUSHalf-yearly Report
31st Jul 20153:40 pmRNSTotal Voting Rights
31st Jul 20153:39 pmRNSBlocklisting Interim Review
25th Jun 20151:21 pmRNSResult of AGM
25th Jun 20157:00 amRNSAGM Statement
2nd Jun 20152:49 pmRNSHolding(s) in Company
27th May 20158:38 amRNSDirector/PDMR Shareholding
22nd Apr 20151:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.